Introduction
Psoriasis (PS) and seborrheic dermatitis (SD) are chronic erythematous-squamous diseases commonly encountered in the community, whose etiology cannot be precisely explained. Although both diseases have benign progression, important pathologies impair the quality of life and affect the social life of the patient (1, 2) .
It is known that racial, geographic, and environmental factors affect papulosquamous diseases (3) (4) (5) (6) (7) (8) (9) . The following have not been correlated with disease etiology but have been presented in several studies: the relationship of these diseases with demographic information such as age, sex, educational status, marital status, and residential area; common chronic diseases in the community such as hypertension (HT), coronary heart disease (CHD), diabetes mellitus (DM), and chronic renal failure (CRF); important pathologies such as obesity and stress; and common habits in the community such as the use of tobacco and alcohol (10) (11) (12) (13) (14) (15) (16) . In this study, we aimed to determine the prevalence of these erythematous-squamous diseases in a region in Turkey and to reveal the frequently encountered associated factors, with the purpose of aiding in planning appropriate healthcare.
Material and methods
A community-based study was conducted in all 12 districts and rural areas of Tokat Province in Turkey between September 2012 and June 2013. Because all citizens are registered in the family medicine system, this system was selected as the baseline for the study. Based on 85 (50%) of the 170 family medicine departments in Tokat Province, 85 sample groups (52 urban, 33 rural) were created. The number of family medicine departments and the number of people included from each department was determined through a multistage proportional cluster sampling method that considered age, sex, and size of rural and urban populations in the province and districts of Tokat's general population pyramid. The volunteer participants were randomly selected among individuals undergoing follow-up at family medicine departments. Only patients aged 20 and over were included in the study. In the same sample group, at most two first-degree relatives were included. The participants' demographic factors, medical history, family history, anthropometry, alcoholic beverage consumption, and tobacco use were recorded. Body mass index (BMI) was calculated as weight (kg) / height (m 2 ). The participants were evaluated according to three age groups: 20-35, 36-65, and 65 years and over. PS and SD were diagnosed clinically by a dermatology specialist. The psoriasis area severity index (PASI) was used to determine the severity of each participant's psoriasis. In this study, PASI scores below 7 were low, scores between 7 and 12 were medium, and scores over 12 were severe. To score SD, the value of scaling, inflammation, and itching was determined (0 = none, 1 = slight, 2 = mild, 3 = moderate, 4 = pronounced, and 5 = severe). Total scores between 2 and 4 were classified as slight, 5-7 were mild, 8-10 were moderate, 11-13 were pronounced, and 14-15 were severe.
The data were evaluated by computer and P < 0.05 was accepted as significant.
Results
A total of 2428 individuals were interviewed, of which 2325 participants were included in the study (1290 females and 1035 males). The age of the participants varied between 20 and 87 years (average age: 47.3 ± 15.3; females: 46.6 ± 15.3, males: 48 ± 15.4).
In the study, PS was diagnosed in 28 (15 women, 53.5%; 13 men, 46.5%) individuals, and the prevalence of PS in the community was 1.2%. No statistically significant difference between sexes was determined (P ≥ 0.05). When the age groups were analyzed, the disease was more common in adults of both sexes (P = 0.003). Psoriasis vulgaris was determined in 27 patients, and palmoplantar pustular psoriasis was determined in only one patient. When family history was analyzed, psoriasis was present in first-degree relatives of 3 (10.7%) patients with PS. Most patients had already been diagnosed with PS, and the time since diagnosis varied between 1 and 45 years (average: 15 years). The average age of onset for the disease was 33 years. A new diagnosis was established for only one patient with few symptoms. Nail involvement was present in 25% (n = 7) of the patients, and nail lesions are given in Table 1 . Joint involvement history was obtained in only one patient. PS lesions were located mostly (64.2%) in the knee-elbow regions ( Table 1 ). The patients' PASI was 7 and lower in 64% (n = 18), between 7 and 12 in 25% (n = 7), and 12 and over in 11% (n = 3). No significant relationship was determined between the PASI score and other factors (P ≥ 0.05). The relationship of the disease with demographic information, common chronic diseases, BMI, and tobacco and alcohol use is presented in Table 2 .
SD was determined in 122 (59 women, 48.4%; 63 men, 51.6%) individuals in the study, and SD prevalence in the community was 5.2%. The prevalence in men (6.1%) was higher than in women (4.6%); however, no statistically significant difference was observed (P = 0.104). When the age groups were analyzed, the disease was encountered in younger ages (P = 0.032). The scalp was the most affected area (94.1%). Other lesion locations, severity score of the disease, and frequency of attacks are presented in Table  3 . No significant relationship was determined between the severity of the disease and other factors (P ≥ 0.05). When the relationship of SD with chronic diseases was analyzed, SD at a high rate was present in 9 (11.1%) of the 81 patients with depression (P = 0.016) and 3 (18.8%) of 13 patients diagnosed with epilepsy (P = 0.015); these rates were statistically significant. No significant relationship was determined with other common diseases (P ≥ 0.05). As the level of education increased, the prevalence of the disease significantly increased (illiterate, 3.6%; elementary education graduates, 4.8%; high school graduates, 7.1%; university graduates, 9%) (P = 0.038). The rate was 4.8% in participants who responded "no" to the question of whether they consume alcohol, 10% for participants who responded "sometimes, " and 8% for participants who responded "yes"; a statistically significant difference was observed between the participants who consume and do not consume alcohol (P = 0.011). SD prevalence increased (25) with the use of tobacco; however, this was not statistically significant (P = 0.141). The relationship of SD with other characteristics is presented in Table 4 .
Discussion
PS and its comorbidities significantly affect quality of life and the clinical results of the disease. They also have significant healthcare costs. In recent years, the relationship of many medical comorbidities, such as DM, HT, SVD, and CHD, with PS has been presented (10) (11) (12) (13) (14) (17) (18) (19) .
In this study, no significant change was observed in PS prevalence when it was evaluated with chronic diseases (Table 2 ). Researchers have emphasized that the frequency of chronic diseases in patients with PS has increased, and these chronic diseases have been associated with PS severity (10, 11, 18, 19) . However, no significant relationship was determined between chronic diseases and PS severity in this study. This could be due to the limited number of patients; PS prevalence was low in the community, and the patients' PASI scores were also low. PS occurs at the same rate in both sexes (20, 21) . The age of disease onset is generally in the third decade; however, onset is possible at any period of life (21) . In this study, the average age of disease onset was 33 years and prevalence was similar in both sexes. When evaluated according to age group, PS was prevalent in adults between 36 and 65 years in both sexes. If psoriasis history is present in the family, the possibility of the disease occurring at an earlier age is high (21, 22) . Whereas psoriasis frequency is 1%-2% in children without psoriasis history in their family, this rate is 10%-20% if the mother or father has psoriasis, and higher than 50% if both parents have psoriasis (21, 22) . In this study, psoriasis anamnesis was determined in firstdegree relatives of 10.7% of the patients. Nail changes are observed in every type of psoriasis. Nail involvement frequency is nearly 50% (23) . The most specific findings encountered in nails are pitting, salmon spots, onycholysis, subungual hyperkeratosis, discoloration, and splinter hemorrhages (23) . In this study, nail involvement was determined in 25% of the patients, and nail findings are presented in Table 1 . No significant difference was specified when the patients were compared to the community in terms of demographic features, tobacco and alcohol use, BMI score, and region of residence (Table 2) .
Several studies have shown that the prevalence of psoriasis varies greatly across the world. In studies conducted in Europe, PS prevalence differed as follows: 8.5% in Norway, 5.2% in France, 3.73% in Denmark, 3.1% in Italy, 2.2% in England, and 1.21% in Croatia (24) (25) (26) (27) (28) (29) (30) . When compared to our results, higher prevalence rates were determined in most studies carried out in Europe. Only the PS prevalence found in the study in Croatia was closer to the value in our study, at 1.21% (29) . However, PS prevalence was lower in studies carried out in Asian countries, such as China and Taiwan (0.47%, China; 0.19%, Taiwan) (4, 5) . On the African continent, low prevalence rates in general and different results were determined. Whereas low PS prevalence was determined in western Sub-Saharan countries such as Ghana and Nigeria (Ghana, 0.4%; Nigeria, 0.9%), the rate was over 2% in eastern SubSaharan African countries (31) (32) (33) . In a study carried out in the United States, PS prevalence was 3.2% (3). In the same study, when ethnic origin was evaluated, PS prevalence differed significantly: 3.6% for Caucasians, 1.9% for African-Americans, and 1.6% for Hispanics (3). PS prevalence in Turkey was higher than in Asia and Africa, and lower than in Europe and the United States. However, in countries on the same continent and even in different ethnic groups in the same country, significant proportional differences occurred. Additionally, when evaluated with all studies, genetic and environmental factors could affect PS development at different rates in different communities.
SD is a common erythematous-squamous disease. It significantly affects patients' quality of life, including social and work life, because the disease is chronic and recurs frequently (2) . In this study, patients mostly mentioned that the lesions were permanent and the disease frequently recurred (Table 3) . SD is associated with several neurological and psychiatric diseases such as neurolepticinduced Parkinsonism, familial amyloidosis with polyneuropathy, tardive dyskinesia, and mood depression (16, (34) (35) (36) . Emotional stress also triggers SD (37) . In this study, SD prevalence was significantly higher in patients who were administered treatment for epilepsy and depression (Table 4 ) (P = 0.015, P = 0.016, respectively). Increased sebum accumulation based upon immobility, neurotransmitter anomalies, and the medication used to treat the diseases have been considered to play a role. However, during treatment for Parkinson disease, sebum secretion production and sometimes SD have recovered (38) (39) (40) (41) .
In the development of the disease, the role of lifestyle and nutrition can be hard to establish. In other studies, the life quality index score of patients with SD with high educational levels was worse than those of others (2, 42) , and in this study, as the patients' educational level increased, SD prevalence increased significantly (P = 0.010) ( Table 4 ). In patients with alcoholism and chronic alcoholic pancreatitis, SD is more common than in the general population (43, 44) . Several studies investigated the increase in lesions due to the use of tobacco and found no relationship (7, 45, 46) . In this study, a significant difference was determined between participants who used and did not use alcohol, as a finding supporting the other studies (P = 0.011). SD was observed more frequently in people who used tobacco than in the community, though this was not statistically significant (Table 4) .
Hyperandrogenism is thought to play an important role in the etiology of SD (47, 48) . The significant frequency of SD in infants (due to maternal hormones) and teenagers, and the faster progression rates in men, are explained with the hyperandrogenism hypothesis (15, 49) . In this study, SD progressed faster in the younger group (P = 0.032) and was more prevalent in men (4.6% females, 6.1% males). Additionally, in another study, SD was more common in obese patients, and this relationship was explained with the hyperandrogenism hypothesis (7). However, in the present study, no significant relationship was determined between BMI and SD. Moreover, one more increase was monitored after the fifth decade as noncompatible with the hyperandrogenism hypothesis in SD frequency (50, 51) . In this study, an increase in SD prevalence was determined after the fifth decade, although it was not statistically significant ( Figure) . SD frequency increases during three time periods: infancy, young adulthood, and after the fifth decade (50,51) (Figure) . Therefore, the age interval chosen in a study can affect SD prevalence. In Brazil, the prevalence was 11% in men of military age; in India, 11.3% in children younger than 12; in Kuwait, 3.1% in children younger than 12; and in Singapore, 3.2% in children younger than 16 (7, 9, 52, 53) . In a similar study carried out in Australia, the prevalence in people older than 20 was high at 9.7% (8) . In the United States, a low rate of 2.85% was determined between 1 and 74 years of age (54) . Consequently, although the global SD prevalence varies between 2% and 12%, the SD prevalence in this study was average at 5.2% (7-9,52-54).
As far as we know, this study is the first communitybased study regarding the prevalence of PS and SD in Turkey. In conclusion, PS prevalence for individuals older than 20 in the northern Anatolian community was 1.2% and SD prevalence was 5.2%. Whereas PS was more common in adults, SD was more common in the young. PS was encountered in both sexes, but SD was slightly more common in men. SD was more prevalent in individuals who used tobacco and especially alcohol. SD prevalence was higher in patients who were administered treatment for depression and epilepsy. Furthermore, as the level of education increased, SD prevalence increased proportionally. 
